
AGYS
NGSAgilysys Inc.
Technology•Software - Application
Watchlists:
Last updated: Monday 21st July 2025
115.21
-4.18 (-3.50%)
Prev Close:119.39
Open:120.29
Bid:114.0
Ask:121.55
52 Week Range
63.71142.64
Volume:273,592
Mkt Cap:3,162 M
53
MarketXLS Rank ®
Hold
Price Target
$132.49
+15.0%
Financial Statements
AGYS - Cash Flow (Annual)
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | |
---|---|---|---|---|---|---|---|---|---|---|
(increase) Decrease In Inventories | -556000.0 | 5 M | -3 M | -6 M | 3 M | -2 M | -50000.0 | 229000.0 | 476000.0 | -2 M |
(increase) Decrease In Other Current Assets | 2 M | -3 M | 124000.0 | -541000.0 | ||||||
(increase) Decrease In Other Current Liabilities | 6 M | 4 M | 6 M | 5 M | -4 M | 4 M | 5 M | -2 M | -4 M | 9 M |
(increase) Decrease In Other Working Capital | -2 M | -36000.0 | -590000.0 | 684000.0 | -228000.0 | 794000.0 | 2 M | |||
(increase) Decrease In Payables | 2 M | 973000.0 | -2 M | 3 M | -7 M | 9 M | -4 M | 130000.0 | 554000.0 | -8 M |
(increase) Decrease In Receivables | -565000.0 | -7 M | 3 M | 3 M | 10 M | -9 M | -8 M | -719000.0 | 6 M | 3 M |
Acquisitions | -146 M | 395000.0 | -24 M | |||||||
Amortization Of Intangibles | 4 M | 1 M | 2 M | 2 M | 2 M | 13 M | 13 M | 12 M | 9 M | 2 M |
Asset Impairment Charge | 24 M | 87000.0 | ||||||||
Capital Expenditure Reported | 3 M | 8 M | 7 M | 1 M | 1 M | 3 M | 3 M | 6 M | 4 M | 6 M |
Cash At Beginning Of Period | 99 M | 47 M | 41 M | 40 M | 49 M | 61 M | 75 M | |||
Cash At End Of Period | -72 M | 32 M | 16 M | 97 M | 99 M | 47 M | 41 M | 40 M | 49 M | 64 M |
Cash Flow | 55 M | 48 M | 34 M | 28 M | 28 M | 11 M | 7 M | 15 M | 15 M | 11 M |
Cash Flow From Continuing Investing Activities | -149 M | -8 M | -7 M | -26 M | -1 M | -3 M | -6 M | -15 M | -14 M | -21 M |
Change In Account Payable | 2 M | 973000.0 | -2 M | 3 M | -7 M | 9 M | -4 M | 130000.0 | 554000.0 | -8 M |
Change In Accrued Expense | 383000.0 | 6 M | 3 M | 146000.0 | 1 M | -4 M | 5 M | 653000.0 | -4 M | 5 M |
Change In Payables And Accrued Expense | 3 M | 7 M | 1 M | 4 M | -6 M | 4 M | 2 M | 783000.0 | -4 M | -3 M |
Change In Prepaid Assets | -84000.0 | -291000.0 | -2 M | -484000.0 | -201000.0 | 2 M | -1 M | 1 M | 2 M | -5 M |
Change In Working Capital | 5 M | 8 M | 4 M | 5 M | 3 M | -544000.0 | -720000.0 | -4 M | 1 M | 3 M |
Changes In Account Receivables | -565000.0 | -7 M | 3 M | 3 M | 10 M | -9 M | -8 M | -719000.0 | 6 M | 3 M |
Current Deferred Income Taxes | 434000.0 | -66 M | -181000.0 | -925000.0 | -959000.0 | -356000.0 | 309000.0 | |||
Deferred Income Taxes | 434000.0 | -66 M | -181000.0 | -925000.0 | -959000.0 | -356000.0 | 309000.0 | |||
Depreciation | 4 M | 4 M | 2 M | 2 M | 3 M | 3 M | 3 M | 3 M | 2 M | 2 M |
Depreciation Unreconciled | 8 M | 5 M | 4 M | 4 M | 5 M | 18 M | 18 M | 15 M | 12 M | 4 M |
Depreciation And Amortization | 8 M | 5 M | 4 M | 4 M | 5 M | 18 M | 18 M | 15 M | 12 M | 4 M |
Effect Of Exchange Rate Changes | -340000.0 | 23000.0 | -628000.0 | -104000.0 | 195000.0 | -130000.0 | -112000.0 | 194000.0 | -74000.0 | -87000.0 |
Financing Cash Flow | 22 M | -9 M | -11 M | -5 M | 25 M | -1 M | -767000.0 | -1 M | -847000.0 | -577000.0 |
Free Cash Flow | 52 M | 40 M | 27 M | 27 M | 27 M | 7 M | 4 M | 734000.0 | -725000.0 | 5 M |
Gain Loss On Sale Of PPE | 25000.0 | -1 M | 66000.0 | 195000.0 | 44000.0 | -5000.0 | 17000.0 | 70000.0 | 381000.0 | |
Issuance Of Capital Stock | 1 M | |||||||||
Issuance Of Capital Stock | 1 M | |||||||||
Issuance Of Debt | 24 M | -2000.0 | -4000.0 | -19000.0 | -24000.0 | -24000.0 | -120000.0 | -124000.0 | -117000.0 | -142000.0 |
Net Cash From Financing Activities | 22 M | -9 M | -11 M | -5 M | 25 M | -1 M | -767000.0 | -1 M | -453000.0 | -577000.0 |
Net Cash From Investing Activities | -149 M | -8 M | -7 M | -26 M | -1 M | -3 M | -6 M | -15 M | -14 M | -21 M |
Net Cash From Operating Activities | 55 M | 48 M | 34 M | 28 M | 28 M | 11 M | 7 M | 7 M | 3 M | 11 M |
Net Change In Cash & Cash Equivalents | -72 M | 32 M | 16 M | -2 M | 52 M | 6 M | 940000.0 | -9 M | -11 M | -11 M |
Net Income From Continuing Operations | 23 M | 86 M | 15 M | 6 M | -21 M | -34 M | -13 M | -4 M | ||
Net Business Purchase And Sale | -146 M | 395000.0 | -24 M | |||||||
Net Common Stock Issuance | 1 M | |||||||||
Net Investment Properties Purchase And Sale | -27000.0 | -27000.0 | -27000.0 | -27000.0 | -2000.0 | -27000.0 | -2 M | -9 M | -10 M | -15 M |
Net Investment Purchase And Sale | -27000.0 | -27000.0 | -27000.0 | -27000.0 | -2000.0 | -27000.0 | -2 M | -9 M | -10 M | -15 M |
Net Issuance Payments Of Debt | 24 M | -2000.0 | -4000.0 | -19000.0 | -24000.0 | -24000.0 | -120000.0 | -124000.0 | -117000.0 | -142000.0 |
Net Long Term Debt Issuance | -26 M | -2000.0 | -4000.0 | -19000.0 | -24000.0 | -24000.0 | -120000.0 | -124000.0 | -117000.0 | -142000.0 |
Net PPE Purchase And Sale | -3 M | -8 M | -7 M | -1 M | -1 M | -3 M | -3 M | -6 M | -4 M | -6 M |
Net Preferred Stock Issuance | 34 M | |||||||||
Operating (gains) Losses | 25000.0 | -1 M | 66000.0 | 195000.0 | 44000.0 | -5000.0 | 17000.0 | 70000.0 | 381000.0 | |
Other Financing Charges Net | -3 M | -7 M | -9 M | -3 M | -8 M | -1 M | -647000.0 | -1 M | -336000.0 | -435000.0 |
Other Investing Changes Net | -27000.0 | -27000.0 | -27000.0 | -27000.0 | -2000.0 | -27000.0 | -2 M | -9 M | -10 M | -15 M |
Other Non-cash Items | 19 M | 16 M | 12 M | 13 M | 43 M | 28 M | 3 M | 4 M | 2 M | 3 M |
Payment Of Cash Dividends | 2 M | 2 M | 2 M | 1 M | ||||||
Preferred Stock Dividend Paid | -2 M | -2 M | -2 M | -1 M | ||||||
Preferred Stock Issuance | 34 M | |||||||||
Purchase Of Property Plant & Equipment | -3 M | -8 M | -7 M | -1 M | -1 M | -3 M | -3 M | -6 M | -4 M | -6 M |
Purchase Of PPE | -3 M | -8 M | -7 M | -1 M | -1 M | -3 M | -3 M | -6 M | -4 M | -6 M |
Repayment Of Debt | -26 M | -2000.0 | -4000.0 | -19000.0 | -24000.0 | -24000.0 | -120000.0 | -124000.0 | -117000.0 | -142000.0 |
Repayment Of Debt | -26 M | -2000.0 | -4000.0 | -19000.0 | -24000.0 | -24000.0 | -120000.0 | -124000.0 | -117000.0 | -142000.0 |
Revenue Per Share | 4 M | 2 M | 2 M | 2 M | 2 M | 15 M | 15 M | 12 M | 9 M | 2 M |
Sale Of PPE | 552000.0 | |||||||||
Stock Based Compensation | 18 M | 14 M | 13 M | 15 M | 40 M | 5 M | 4 M | 5 M | 2 M | 3 M |